55 related articles for article (PubMed ID: 19288010)
1. Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma.
Tsunoda S; Smith E; De Young NJ; Wang X; Tian ZQ; Liu JF; Jamieson GG; Drew PA
Oncol Rep; 2009 Apr; 21(4):1067-73. PubMed ID: 19288010
[TBL] [Abstract][Full Text] [Related]
2. Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.
Lee SM; Park JY; Kim DS
Mol Cells; 2012 Aug; 34(2):171-6. PubMed ID: 22814847
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor 2: Current understanding, challenges, and future perspectives.
Kobayashi H; Matsubara S; Yoshimoto C; Shigetomi H; Imanaka S
J Obstet Gynaecol Res; 2023 Nov; 49(11):2575-2583. PubMed ID: 37549932
[TBL] [Abstract][Full Text] [Related]
4. Author Correction: Intravitreal injection of fibrillin 2 (Fbn2) recombinant protein for therapy of retinopathy in a retina-specific Fbn2 knock-down mouse model.
Zhang RX; Wen Y; Guo DD; Xu FR; Wang GM; Wang XR; Shi YW; Ding J; Jiang Q; Jiang WJ; Jonas JB; Bi HS
Sci Rep; 2023 Nov; 13(1):19992. PubMed ID: 37968571
[No Abstract] [Full Text] [Related]
5. TFPI2 is key for cancer stem cell-microglia symbiosis in glioblastoma.
Nat Immunol; 2023 Oct; 24(10):1612-1613. PubMed ID: 37667053
[No Abstract] [Full Text] [Related]
6. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of claudins in cancer.
Tao D; Guan B; Li H; Zhou C
Heliyon; 2023 Nov; 9(11):e21338. PubMed ID: 37954388
[TBL] [Abstract][Full Text] [Related]
8. A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions.
Li Y; Li B; Jiang R; Liao L; Zheng C; Yuan J; Zeng L; Hu K; Zhang Y; Mei W; Hong Z; Xiao B; Kong L; Han K; Tang J; Jiang W; Pan Z; Zhang S; Ding P
Cancer Med; 2023 Nov; 12(21):20626-20638. PubMed ID: 37881109
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of
He Z; Fan F; Xu Z; Zhang M; Zhao R; Ke X; Wang Q; Yan S; Zheng H
Transl Cancer Res; 2023 Jul; 12(7):1753-1764. PubMed ID: 37588735
[TBL] [Abstract][Full Text] [Related]
10. Role of fibrilins in human cancer: A narrative review.
Mahdizadehi M; Saghaeian Jazi M; Mir SM; Jafari SM
Health Sci Rep; 2023 Jul; 6(7):e1434. PubMed ID: 37469709
[TBL] [Abstract][Full Text] [Related]
11. Tight Junction Protein Signaling and Cancer Biology.
Nehme Z; Roehlen N; Dhawan P; Baumert TF
Cells; 2023 Jan; 12(2):. PubMed ID: 36672179
[TBL] [Abstract][Full Text] [Related]
12. Positive Expression of Retinol-Binding Protein 4 Is Related to the Malignant Clinical Features Leading to Poor Prognosis of Glioblastoma.
Deng X; Ren J; Bi Z; Fu Z
Genet Res (Camb); 2022; 2022():5435523. PubMed ID: 36632438
[TBL] [Abstract][Full Text] [Related]
13. miR-139-5p Was Identified as Biomarker of Different Molecular Subtypes of Breast Carcinoma.
Sun H; Dai J; Chen M; Chen Q; Xie Q; Zhang W; Li G; Yan M
Front Oncol; 2022; 12():857714. PubMed ID: 35433464
[TBL] [Abstract][Full Text] [Related]
14. CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers.
Qu H; Jin Q; Quan C
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948213
[TBL] [Abstract][Full Text] [Related]
15. Claudin 6: Therapeutic prospects for tumours, and mechanisms of expression and regulation (Review).
Du H; Yang X; Fan J; Du X
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296304
[TBL] [Abstract][Full Text] [Related]
16. Claudin-1/4 as directly target gene of HIF-1α can feedback regulating HIF-1α by PI3K-AKT-mTOR and impact the proliferation of esophageal squamous cell though Rho GTPase and p-JNK pathway.
Liu H; Zhang Z; Zhou S; Liu X; Li G; Song B; Xu W
Cancer Gene Ther; 2022 Jun; 29(6):665-682. PubMed ID: 34276052
[TBL] [Abstract][Full Text] [Related]
17. Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma.
Gu HY; Zhang C; Guo J; Yang M; Zhong HC; Jin W; Liu Y; Gao LP; Wei RX
Aging (Albany NY); 2020 Feb; 12(4):3807-3827. PubMed ID: 32084007
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B.
Cao X; He GZ
Onco Targets Ther; 2018; 11():6351-6360. PubMed ID: 30319275
[TBL] [Abstract][Full Text] [Related]
19. Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han Population.
Wang C; Pu W; Zhao D; Zhou Y; Lu T; Chen S; He Z; Feng X; Wang Y; Li C; Li S; Jin L; Guo S; Wang J; Wang M
Front Genet; 2018; 9():356. PubMed ID: 30233644
[TBL] [Abstract][Full Text] [Related]
20. RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer.
Fei W; Chen L; Chen J; Shi Q; Zhang L; Liu S; Li L; Zheng L; Hu X
Oncotarget; 2017 Nov; 8(54):92254-92264. PubMed ID: 29190912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
